Spatial mapping of proteins and their activity states in cancer models by multiplex in situ PLA
Preprint
Abstract
Improved methods are needed to gain insights in how proteins exert their myriad roles in cells and organs. Multiplex in situ proximity ligation assay (misPLA), described herein, can provide a window into the functional states of proteins in cells and tissues by applying pairs of antibody–oligonucleotide conjugates to generate amplifiable DNA circles upon proximal binding. The analysis reveals interactions and modifications among sets of proteins, read out by recording the identity and location of the resulting localized DNA amplification products. We applied misPLA to both primary and cultured cells and to formalin-fixated paraffin-embedded (FFPE) tissues, to map dynamic changes in protein localizations, phosphorylations and interactions across surface markers, MAPK, immune-checkpoints, T- and B-cell receptors, and adhesion panels. Comparisons of single-plex versus nine-plex assays confirmed that misPLA maintains sensitivity and specificity while increasing throughput and spatial context. Across breast cancer, lymphomas and chronic myeloid leukemia (CML) misPLA uncovered shared and disease-specific signaling patterns, underscoring convergence of oncogenic networks. By preserving tissue architecture and enabling high-content functional spatial proteomics at single-cell resolution, misPLA offers a versatile platform for dissecting signaling heterogeneity, pathway crosstalk, and therapeutic responses, with broad applications in cell biology, biomarker discovery and in precision oncology.Keywords
This publication has 26 references indexed in Scilit:
- A Response to the Letter to the Editor: “In Situ Detection of Programmed Cell Death Protein 1 and Programmed Death Ligand 1 Interactions as a Functional Predictor for Response to Immune Checkpoint Inhibition in NSCLC”Journal of Thoracic Oncology, 2025
- TissUUmaps 3: Improvements in interactive visualization, exploration, and quality assessment of large-scale spatial omics dataHeliyon, 2023
- Targeting the JAK-STAT pathway in autoimmune diseases and cancers: A focus on molecular mechanisms and therapeutic potentialBiochemical Pharmacology, 2021
- Mechanisms of Resistance to ABL Kinase Inhibition in Chronic Myeloid Leukemia and the Development of Next Generation ABL Kinase InhibitorsHematology/Oncology Clinics of North America, 2017
- In situ sequencing for RNA analysis in preserved tissue and cellsNature Methods, 2013
- The JAK-STAT Pathway at TwentyImmunity, 2012
- Interactome Networks and Human DiseaseCell, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- The Age of Crosstalk: Phosphorylation, Ubiquitination, and BeyondMolecular Cell, 2007
- Direct observation of individual endogenous protein complexes in situ by proximity ligationNature Methods, 2006